CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback